Sven E. Hoffner

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed Strategies.

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed Strategies.

Journal: Medicinal research reviews

Published: December 09, 2025

Editorial: Rising stars in tuberculosis.

Editorial: Rising stars in tuberculosis.

Journal: Frontiers in tuberculosis

Published: May 26, 2025

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Journal: Frontiers in tuberculosis

Published: November 29, 2024

Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test.

Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test.

Journal: International journal of mycobacteriology

Published: January 06, 2024

Exploring the Genetic Landscape of Mycobacterium tuberculosis: Unlocking the Differences in Between Latent and Active Tuberculosis.

Exploring the Genetic Landscape of Mycobacterium tuberculosis: Unlocking the Differences in Between Latent and Active Tuberculosis.

Journal: International journal of mycobacteriology

Published: September 02, 2023

Novel and reported compensatory mutations in rpoABC genes found in drug resistant tuberculosis outbreaks.

Novel and reported compensatory mutations in rpoABC genes found in drug resistant tuberculosis outbreaks.

Journal: Frontiers in microbiology

Published: July 22, 2023

Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics.

Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: February 13, 2023

Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran.

Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran.

Journal: International journal of mycobacteriology

Published: December 13, 2022

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis.

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: October 30, 2022

Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study.

Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study.

Journal: Antimicrobial agents and chemotherapy

Published: May 09, 2022

Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis.

Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis.

Journal: mBio

Published: February 01, 2022

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis.

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: June 28, 2021

Showing 1-12 of 95

Last Updated: 09/26/2026